- AdventHealth Research Institute
Alzheimer’s disease is often thought of as a disease of aging, but scientists are increasingly recognizing that biology also plays an important role. For women, the risk appears to be significantly higher. To better understand what researchers are learning, we asked Lauren Oberlin, PhD, an investigator at the AdventHealth Research Institute, to answer some of the most important questions about women and brain health.
Many people do not realize that Alzheimer’s disease affects women differently than men. What do we know about that today?
Dr. Oberlin:
One of the most striking facts about Alzheimer’s disease is that women are disproportionately affected. In the United States, nearly two thirds of people living with Alzheimer’s are women. That means roughly twice as many women as men are living with the disease. For researchers, that statistic raises an important question. Why are women at greater risk?
For years people assumed the explanation was simple because women live longer. Is that still the thinking?
Dr. Oberlin:
That was the common explanation for a long time, but research now shows that lifespan alone does not explain the difference. Women do tend to live longer on average, but longevity accounts for only part of the increased risk. Scientists now believe other biological factors are involved, including differences in hormones, immune function, and genetics that may influence how Alzheimer’s disease develops.
Why has it taken so long for researchers to focus on these differences between men and women?
Dr. Oberlin:
Historically, biomedical research did not consistently examine sex differences when studying disease. A widely cited paper published in Alzheimer’s and Dementia highlighted this gap and called attention to how poorly sex specific factors had been integrated into Alzheimer’s research. That lack of focus has limited our understanding of the disease and may have slowed progress in developing effective treatments.
What kinds of biological differences are scientists now investigating?
Dr. Oberlin:
Researchers are exploring several possible mechanisms. Hormonal changes, particularly those that occur during menopause, may influence brain health and Alzheimer’s risk. Scientists are also studying how the immune system behaves differently in women and how certain genes associated with Alzheimer’s disease may affect women and men in different ways. These factors likely interact in complex ways that we are only beginning to understand.
Scientists are starting to uncover clues about what may drive this difference in risk. What are some of the most interesting discoveries emerging from research right now?
Dr. Oberlin:
One exciting area of research is identifying biological mechanisms that may contribute to the higher risk we see in women. Scientists are beginning to find evidence that certain pathways in the brain and immune system may function differently in women compared with men. When researchers can identify these mechanisms, it helps us better understand how the disease develops and where new opportunities for prevention or treatment may exist.
Why is understanding the reason behind this difference so important for treatment?
Dr. Oberlin:
Alzheimer’s disease is complex, and treatments that work for one group of people may not work the same way for another. If researchers can identify the biological pathways that increase risk in women, it may allow us to develop therapies that are more precise and more effective. Understanding these mechanisms is a critical step toward more personalized approaches to brain health.
What should women take away from this research right now?
Dr. Oberlin:
One of the most important messages is that brain health is closely connected to overall health. Factors such as cardiovascular health, metabolic health, sleep, physical activity, and cognitive engagement all influence how the brain ages. While scientists continue to study the biology behind Alzheimer’s risk, there are already many steps women can take to support brain health throughout their lives.
How is the AdventHealth Research Institute contributing to this work?
Dr. Oberlin:
Researchers at the AdventHealth Research Institute are working to better understand how biological, metabolic, and lifestyle factors influence brain health across the lifespan. By studying these connections, the goal is to identify new opportunities for earlier detection, prevention, and more personalized care for conditions like Alzheimer’s disease.
Lauren E. Oberlin, PhD is a researcher at the AdventHealth Research Institute studying how metabolism, hormones, and aging influence brain health in women.
Recent News
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...
Weight-Loss Drugs, Hormones, and Midlife: What Women Need to Know
Understanding the connection between GLP-1 medications and hormone therapy
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.
MANIFEST US Study Presented as a Late-Breaking Clinical Trial at AHA
The cardiovascular team is excited to highlight the MANIFEST US study, which was presented on November 10th as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific...
Nourishing Your Gut: Dr. Karen Corbin on the Power of Fiber
Dr. Karen Corbin, associate investigator at the AdventHealth Translational Research Institute for Metabolism and Diabetes in Orlando, emphasizes the essential role of diet in maintaining a healthy gut...
Southeast Region – Redmond Campus: AdventHealth Recognized as Top Enroller Nationally for the CARVTOP-ICD Trial
AdventHealth Research Institute (AHRI) is proud to announce that the Southeast Region’s Redmond Campus has been recognized as the top enrolling site nationally for the CARVTOP-ICD trial.